ECU
IONS icon

Eisler Capital (US)’s Ionis Pharmaceuticals IONS Stock Holding History

Eisler Capital (US)’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$3.81M Buy
+95,000
New +$4.42M 0.08% 241

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
TBC
Tweedy, Browne Co Stamford, Connecticut $1.32B AUM 32.9% 1-Year Est. Return

Eisler Capital (US)'s IONS Position: Q3 2024 in Review

Eisler Capital (US) increased its Ionis Pharmaceuticals (IONS) stake by 623% in Q3 2024, buying an estimated $4.71M and bringing the position to 117,565 shares worth $4.71M. The position accounts for 0.1% of the portfolio, ranked #209.

Eisler Capital (US) first reported a position in IONS in Q2 2024 and has held it in 2 quarters since. 354 funds tracked by Wall St. Rank hold IONS as of Q3 2024.

  • Eisler Capital (US) held 117,565 shares of Ionis Pharmaceuticals worth $4.71M as of Q3 2024.
  • Eisler Capital (US) bought 101,295 Ionis Pharmaceuticals shares in Q3 2024, an estimated $4.71M.
  • Ionis Pharmaceuticals made up 0.1% of Eisler Capital (US)'s portfolio in Q3 2024, its #209 holding.
  • Eisler Capital (US) first reported a position in Ionis Pharmaceuticals in Q2 2024 and has held it in 2 quarters since.
  • 354 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2024.

Based on Eisler Capital (US)'s 13F filing for Q3 2024, filed 14 Nov 2024.